Heterogeneous nuclear ribonucleoprotein H1, a novel nuclear autoantigen

Clinical Chemistry

Volumn 55, Issue 5, 2009, Pages 946-954

  Van Den Bergh, Karolien ^a   Hooijkaas, Herbert ^b   Blockmans, Daniel ^a   Westhovens, René ^a   De Beéck, Katrijn Op ^a   Verschueren, Patrick ^a   Dufour, Diana ^b   Van De Merwe, Joop P ^b   Fijak, Monika ^c   Klug, Jörg ^c   Michiels, Georges ^a   Devogelaere, Benoit ^d   De Smedt, Humbert ^d   Derua, Rita ^e   Waelkens, Etienne ^e   Blanckaert, Norbert ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; RIBONUCLEOPROTEIN H1; RIBONUCLEOPROTEIN H1 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; BLOTTING, WESTERN; COHORT STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP F-H; HUMANS; MALE; MIDDLE AGED; RATS; RECOMBINANT PROTEINS; ROC CURVE; SJOGREN'S SYNDROME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

RATTUS;

EID: 65949117621     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.115626     Document Type: Article

References (40)

1. Fox PC. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy. Ann NY Acad Sci 2007;1098:15-21. (Pubitemid 47092524)
2. Fox RI. Sjogren's syndrome. Lancet 2005;366:321-331
3. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71-81.
4. Gao J, Cha S, Jonsson R, Opalko J, Peck AB. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren syndrome patients by use of a transfected cell line assay. Arthritis Rheum 2004;50:2615-2621 (Pubitemid 39062723)
5. Billaut-Mulot O, Cocude C, Kolesnitchenko V, Truong MJ, Chan EK, Hachula E, et al. SS-56, a novel cellular target of autoantibody responses in Sjögren's syndrome and systemic lupus erythematosus. J Clin Invest 2001;108:861-869
6. Arakaki R, Ishimaru N, Saito I, Kobayashi M, Yasui N, Sumida T, Hayashi Y. Development of autoimmune exocrinopathy resembling Sjogren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells. Arthritis Rheum 2003;48:3603-3609 (Pubitemid 37531928)
7. Willeke P, Gaubitz M, Schotte H, Becker H, Mickholz E, Domschke W, Schluter B. Clinical and immunological characteristics of patients with Sjogren's syndrome in relation to alpha-fodrin antibodies. Rheumatology (Oxford) 2007;46:479-483 (Pubitemid 46344662)
8. Sordet C, Gottenberg JE, Goetz J, Bengoufa D, Humbel RL, Mariette X, Sibilia J. Anti-{alpha}- fodrin autoantibodies are not useful diagnostic markers of primary Sjogren syndrome. Ann Rheum Dis 2005;64:1244-1245 (Pubitemid 41113373)
9. Kovacs L, Marczinovits I, Gyorgy A, Toth GK, Dorgai L, Pal J, et al. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome. Rheumatology (Oxford) 2005;44:1021-1025
10. Bossuyt X, Hendrickx A, Frans J. Antinuclear antibody titer and antibodies to extractable nuclear antigens. Arthritis Rheum 2005;53:987-988 (Pubitemid 41811144)
11. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590
14. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328-346 (Pubitemid 34136570)
15. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56:255-286 (Pubitemid 8130612)
16. Alarcón-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989;16:328-334
17. Walravens MJ, Vanherrewegen H, Lacquet F, Godefridis G, Korevits G, Stevens E, et al. Counter-immunoelectrophoresis with serum prediffusion: an improved method for the detection and identification of antibodies against extractable nuclear and cytoplasmic antigens. J Immunol Methods 1997;201:89-98.
18. Fijak M, Iosub R, Schneider E, Linder M, Respondek K, Klug J, Meinhardt A. Identification of immunodominant autoantigens in rat autoimmune orchitis. J Pathol 2005;207:127-138 (Pubitemid 41404143)
19. Devogelaere B, Beullens M, Sammels E, Derua R, Waelkens E, Van Lint J, et al. Protein phosphatase-1 is a novel regulator of the interaction between IRBIT and the inositol 1,4,5-triphosphate receptor. Biochem J 2007;407: 303-311
20. Holzmann K, Korosec T, Gerner C, Grimm R, Sauermann G. Identification of human common nuclear-matrix proteins as heterogeneous nuclear ribonucleoproteins H and H′ by sequencing and mass spectrometry. Eur J Biochem 1997;244:479-486 (Pubitemid 27110751)
21. Schisterman, EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 2005;16:73-81. (Pubitemid 40239280)
22. Bossuyt X, Frans J, Hendrickx A, Godefridis G, Westhovens R, Marien G. Detection of anti-SSA antibodies by indirect immunofluorescence. Clin Chem 2004;50:2361-2369 (Pubitemid 39552173)
23. De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F. The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus 2005;14:931-937 (Pubitemid 43088266)
24. Stein AJ, Fuchs G, Fu C, Wolin SL, Reinisch KM. Structural insights into RNA quality control: the Ro autoantigen binds misfolded RNAs via its central cavity. Cell 2005;121:529-539 (Pubitemid 40720007)
25. Fan H, Goodier JL, Chamberlain JR, Engelke DR, Maraia RJ. 5′ processing of tRNA precursors can be modulated by the human La antigen phosphoprotein. Mol Cell Biol 1998;18:3201-3211 (Pubitemid 28240493)
26. Belisova A, Semrad K, Mayer O, Kocian G, Weigmann E, Schroeder R, Steiner G. RNA chaperone activity of protein components of human Ro RNPs. RNA 2005;11:1084-1094 (Pubitemid 40994189)
27. Caporali R, Bugatti S, Bruschi E, Cavagna L, Montecucco C. Autoantibodies to heterogeneous nuclear ribonucleoproteins. Autoimmunity 2005;38:25-32. (Pubitemid 40515000)
28. Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, Murray GI. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 2006;1765:85-100.
29. Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen. Autoimmunity 2007;40:223-233 (Pubitemid 46680976)
30. Fabini G, Raijmakers R, Hayer S, Fouraux MA, Pruijn GJM, Steiner G. The heterogeneous nuclear ribonucleoproteins I and K interact with a subset of the Ro ribonucleoprotein-associated Y RNAs in vitro and in vivo. J Biol Chem 2001;20711-20718
31. Jensen L, Kuff EL, Wilson SH, Steinberg AD, Klinman DM. Antibodies from patients and mice with autoimmune diseases react with recombinant hnRNP core protein A1. J Autoimmun 1988 1:73-83.
32. Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I, Smolen JS. Autoimmune response to the spliceosome: an immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum 1995;38:777-785
33. Montecucco C, Caporali R, Cobianchi F, Biamonti G. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis. Arthritis Rheum 1996;39:1669-1676 (Pubitemid 26331020)
34. Heegaard NH, Larsen MR, Muncrief T, Wiik A, Roepstorff P. Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods. Arthritis Res 2000;2:407-414 (Pubitemid 32223779)
35. Skriner K, Hueber W, Süleymanoglu E, Höfler E, Krenn V, Smolen J, Steiner G. AUF1, the regulator of tumor necrosis factor α messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases. Arthritis Rheum 2008;58:511-520
36. Schaub MC, Lopez SR, Caputi M. Members of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexes. J Biol Chem 2007;282:13617-13626 (Pubitemid 47100498)
37. Alkan SA, Martincic K, Milcarek C. The hnRNPs F and H2 bind to similar sequences to influence gene expression. Biochem J 2006;393:361-371 (Pubitemid 43049333)
38. Dominguez C, Allain FH. NMR structure of the three quasi RNA recognition motifs (qRRMs) of human hnRNP F and interaction studies with Bcl-x G-tract RNA: a novel mode of RNA recognition. Nucleic Acids Res 2006;34:3634-3645 (Pubitemid 44400413)
39. Chou MY, Rooke N, Turck CW, Black DL. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol Cell Biol 1999;19:69-77. (Pubitemid 29018410)
40. Sisto M, Lisi S, Castellana D, Scagliusi P, D'Amore M, Caprio S, et al. Autoantibodies from Sjögren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J. Autoimmun 2006;27:38-49.